These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 12201856

  • 21. An Updated Review of Food and Drug Administration Warning and Untitled Letters for Clinical Outcome Assessment Claims Between 2013 and 2021.
    Sams L, Slagle AF, Symonds T, Antonova J, Globe D.
    Value Health; 2023 Dec; 26(12):1675-1680. PubMed ID: 37748736
    [Abstract] [Full Text] [Related]

  • 22. Violations of exhibiting and FDA rules at an American Psychiatric Association annual meeting.
    Lurie P, Tran T, Wolfe SM, Goodman R.
    J Public Health Policy; 2005 Dec; 26(4):389-99. PubMed ID: 16392738
    [Abstract] [Full Text] [Related]

  • 23. A study of warning letters issued to clinical investigators by the United States Food and Drug Administration.
    Bramstedt KA.
    Clin Invest Med; 2004 Jun; 27(3):129-34. PubMed ID: 15305804
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The ban on "off-label" pharmaceutical promotion: constitutionally permissible prophylaxis against false or misleading commercial speech?
    Greenwood K.
    Am J Law Med; 2011 Jun; 37(2-3):278-98. PubMed ID: 21847882
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Research Misconduct in FDA-Regulated Clinical Trials: A Cross-sectional Analysis of Warning Letters and Disqualification Proceedings.
    Garmendia CA, Bhansali N, Madhivanan P.
    Ther Innov Regul Sci; 2018 Sep; 52(5):592-605. PubMed ID: 29714564
    [Abstract] [Full Text] [Related]

  • 34. Complaints, complainants, and rulings regarding drug promotion in the United Kingdom and Sweden 2004-2012: a quantitative and qualitative study of pharmaceutical industry self-regulation.
    Zetterqvist AV, Merlo J, Mulinari S.
    PLoS Med; 2015 Feb; 12(2):e1001785. PubMed ID: 25689460
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.